Targeted imaging of bacterial infections: Advances, hurdles and hopes

FEMS Microbiology Reviews

Volumn 39, Issue 6, 2015, Pages 892-916

  van Oosten, Marleen ^a   Hahn, Markus ^a   Crane, Lucia M A ^a   Pleijhuis, Rick G ^a   Francis, Kevin P ^b   van Dijl, Jan Maarten ^a   van Dam, Gooitzen M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PERKINELMER INC   (United States)

Author keywords

Bacteria; Fluorescence; Imaging; Infection; Radioisotope; Tracer

Indexed keywords

ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; MOLECULAR PROBE;

AGING; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN ANTIBODY COMPLEX; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIUM; BIOLUMINESCENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DNA DEGRADATION; FLUORESCENCE IMAGING; HEALTH CARE; HUMAN; INFECTION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOACOUSTICS; REVIEW; RNA HYBRIDIZATION; BACTERIAL INFECTIONS; DIAGNOSTIC PROCEDURE; MOLECULAR PROBE; STANDARDS; TRENDS;

BACTERIAL INFECTIONS; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MOLECULAR PROBES;

EID: 84947556887     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1093/femsre/fuv029     Document Type: Review

References (123)

1. 99m)Tc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol I 2008;35:1056-64.
2. Akhtar MS, Imran MB, Nadeem MA, et al. Antimicrobial peptides as infection imaging agents: better than radiolabeled antibiotics. Int J Pept 2012;2012:965238.
3. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med 2004;45:849-56.
4. 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 2005;46:567-73.
5. Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 2014;12:465-78.
6. 99mTc-methylene diphosphonate scintigraphy and magnetic resonance imaging. Nucl Med Commun 2011;32:716-23.
7. Azhdarinia A, Ghosh P, Ghosh S, et al. Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol 2012;14:261-76.
8. Bardhan NM, Ghosh D, Belcher AM. Carbon nanotubes as in vivo bacterial probes. Nat Commun 2014;5:4918.
9. Bettegowda C, Foss CA, Cheong I, et al. Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. P Natl Acad Sci USA 2005;102:1145-50.
10. Bhatti M, MacRobert A, Henderson B, et al. Antibody-targeted lethal photosensitization of Porphyromonas gingivalis. Antimicrob Agents Ch 2000;44:2615-8.
11. 99m)Tc-ciprofloxacin (Infecton). J Clin Pathol 2002;55:817-23.
12. Bryant RE, Mazza JA. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am J Med 1989;87: 23S-7S.
13. Bunschoten A, Welling MM, Termaat MF, et al. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjugate Chem 2013;24: 1971-89.
14. Buscombe JR, Oyen WJ, Corstens FH, et al. A comparison of 111In-HIG scintigraphy and chest radiology in the identification of pulmonary infection in patients with HIV infection. Nucl Med Commun 1995;16:327-35.
15. Buscombe JR, Oyen WJ, Grant A, et al. Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus. J Nucl Med 1993;34:1621-5.
16. 99mTc-labelled polyclonal human immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection. Eur J Nucl Med 1991a;18:396-400.
17. 99mlabeled polyclonal human immunoglobulin. J Nucl Med 1991b;32:468-74.
18. Calame W, Welling M, Feitsma HI, et al. Improved detection of a staphylococcal infection by monomeric and protein A-purified polyclonal human immunoglobulin. Eur J Nucl Med 1993;20:490-4.
19. 99m)Tc-moxifloxacin, a potential infection specific imaging agent. Appl Radiat Isotopes 2010;68:314-6.
20. 99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents. Bioorg Med Chem 2013;21:6523-30.
21. Chevalier C, Boisset S, Romilly C, et al. Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation. PLoS Pathog 2010;6:e1000809
22. ColditzMJ, Jeffree RL. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: clinical, radiological and pathological studies. J Clin Neurosci 2012;19:1471-4.
23. Dahiya S, Chuttani K, Khar RK, et al. Synthesis and evaluation of ciprofloxacin derivatives as diagnostic tools for bacterial infection by Staphylococcus aureus. Metallomics 2009;1:409-17.
24. Demidova TN, Hamblin MR. Photodynamic therapy targeted to pathogens. Int J Immunopath Ph 2004;17:245-54.
25. Diaz LA Jr, Foss CA, Thornton K, et al. Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One 2007;2:e1007.
26. Dosselli R, Tampieri C, Ruiz-González R, et al. Synthesis, characterization, and photoinduced antibacterial activity of porphyrin-type photosensitizers conjugated to the antimicrobial peptide apidaecin 1b. J Med Chem 2013;56:1052-63.
27. Dumarey N, Blocklet D, Appelboom T, et al. Infection is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol I 2002;29:530-5.
28. Ebenhan T, Zeevaart JR, Venter JD, et al. Preclinical evaluation of 68Ga-labeled 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acidubiquicidin as a radioligand for PET infection imaging. J Nucl Med 2014;55:308-14.
29. Elias DR, Thorek DL, Chen AK, et al. In vivo imaging of cancer biomarkers using activatable molecular probes. Cancer Biomark 2008;4:287-305.
30. 99mTc-N-sulfanilamide ferrocene carboxamide as bacterial infections detector. Nucl Med Biol 2010;37:821-9.
31. 99mTc-UBI specificity for bacteria. Nucl Med Biol 2003;30:597-603.
32. 18F-labeled trovafloxacin in normal and Escherichia coliinfected rats and rabbits studied with positron emission tomography. Clin Microbiol Infec 1997;3:63-72.
33. 18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Ch 1998;42:2048-54.
34. 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Ch 1992;36:2286-92.
35. 18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. Antimicrob Agents Ch 1996;40:659-64.
36. Fischman AJ, Rubin RH, White JA, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990;31:1199-205.
37. Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol Lett 1994;118:199-205.
38. 99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol 2009;36:199-205.
39. 18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS One 2014;9:e107951.
40. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 1998;51:215-9.
41. Hellebust A, Richards-Kortum R. Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine 2012;7:429-45.
42. Hernandez FJ, Huang L, Olson ME, et al. Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat Med 2014;20:301-6.
43. Hiemstra PS, van den Barselaar MT, Roest M, et al. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukocyte Biol 1999;66:423-8.
44. 99m)Tc-clindamycin: an infection imaging agent. Appl Biochem Biotech 2014;174:1420-33.
45. Jalilian AR, Hosseini MA, Majdabadi A, et al. Evaluation of [(201)Tl](III) vancomycin in normal rats. Nucl Med Rev Cent East Eur 2008;11:1-4.
46. 99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection. Int J Infect Dis 2012;17:e263-70.
47. Kharkwal GB, Sharma SK, Huang YY, et al. Photodynamic therapy for infections: clinical applications. Laser Surg Med 2011;43:755-67.
48. Kong Y, Yao H, Ren H, et al. Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. P Natl Acad Sci USA 2010;107:12239-44.
49. Kumar V, Boddeti DK, Evans SG, et al. Potential use of 68Ga-apotransferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nucl Med Biol 2011;38:393-8.
50. Langer O, BrunnerM, ZeitlingerM, et al. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol I 2004;32:143-50.
51. Lee JD, Shin KH, Cho SN, et al. Immunoscintigraphy in the detection of tuberculosis with radiolabelled antibody fragment against Mycobacterium bovis Bacillus Calmette-Guérin: a preliminary study in a rabbit model. Eur J Nucl Med 1992;19: 1011-5.
52. Lee S, Chen X. Dual-modality probes for in vivo molecular imaging. Mol Imaging 2009;8:87-100.
53. Leevy WM, Gammon ST, Johnson JR, et al. Noninvasive optical imaging of Staphylococcus aureus bacterial infection in living mice using a bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjugate Chem 2008a;19:686-92.
54. Leevy WM, Lambert TN, Johnson JR, et al. Quantum dot probes for bacteria distinguish Escherichia colimutants and permit in vivo imaging. Chem Commun 2008b;20:2331-3.
55. Lemaire S, Kosowska-Shick K, Julian K, et al. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 2008;14:766-77.
56. 18F-FDS and its potential application in molecular imaging. Mol Imaging Biol 2008;10:92-8.
57. Liu L, Xu Y, Shea C, et al. Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. J Med Chem 2010;53:2882-91.
58. Liu XR, Cheng DF, Gray BD, et al. Radiolabeled Zn-DPA as a potential infection imaging agent. Nucl Med Biol 2012;39:709-14.
59. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol 2004;32:47-57.
60. Love C, Tomas MB, Tronco GG, et al. FDG PET of infection and inflammation. Radiographics 2005;25:1357-68.
61. Lupetti A, Welling MM, Pauwels EK, et al. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 2003;3:223-9.
62. 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection. Clin Microbiol Infec 2003;9:101-9.
63. Malpani BL, Kadival GV, Samuel AM. Radioimmunoscintigraphic approach for the in vivo detection of tuberculomas-a preliminary study in a rabbit model. Int J Rad Appl Instrum B 1992;19:45-53.
64. Martínez ME, Kiyono Y, Noriki S, et al. New radiosynthesis of 2-deoxy-2-[(18)F]fluoroacetamido-D-glucopyranose and its evaluation as a bacterial infections imaging agent. Nucl Med Biol 2011;38:807-17.
65. 99m)Tc-UBI 29-41 in humans. Nucl Med Biol 2004;31:373-9.
66. Mitsunaga M, Nakajima T, Sano K, et al. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer 2012;12:345.
67. Mitsunaga M, Ogawa M, Kosaka N, et al. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011;17:1685-91.
68. Mokaleng BB, Ebenhan T, Ramesh S, et al. Synthesis, (68)Garadiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent. Biomed Res Int 2015;2015:284354.
69. Mukherjee A, Wickstrom E, Thakur ML. Imaging oncogene expression. Eur J Radiol 2009;70:265-73.
70. Nakamura K, Fan C, Liu G, et al. Evidence of antisense tumor targeting in mice. Bioconjugate Chem 2004;15:1475-80
71. 99m)Tc(i)-tricarbonyl complexes of fluoroquinolones for targeting bacterial infection. Metallomics 2012;4:1197-208.
72. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents inmice infectedwith Staphylococcus aureus. J Nucl Med 2004;45:321-6.
73. Nijhof MW, Oyen WJ, van Kampen A, et al. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med 1997;38:1300-5.
74. Ning X, Lee S, Wang Z, et al. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater 2011;10:602-7.
75. Ntziachristos V, Razansky D. Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem Rev 2010;110:2783-94.
76. Panizzi P, Nahrendorf M, Figueiredo JL, et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogenspecific prothrombin activation. Nat Med 2011;17:1142-6.
77. Pascual A, García I, Ballesta S, et al. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissuecultured epithelial cells. Antimicrob Agents Ch 1997;41:274-7.
78. Peterson KL, Reid WC, Freeman AF, et al. The use of 14CFIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging. Nucl Med Biol 2013;40:638-42.
79. Petrik M, Haas H, Schrettl M, et al. In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging. Nucl Med Biol 2012;39:361-9.
80. Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 2012;194:4494-504.
81. Pullambhatla M, Tessier J, Beck G, et al. [(125)I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load. Am J Nucl Med Mol Imaging 2012;2:260-70.
82. Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol 2010;65:500-16.
83. Ragàs X, Sánchez-García D, Ruiz-González R, et al. Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. J Med Chem 2010;53:7796-803.
84. Rajesh S, Koshi E, Philip K, et al. Antimicrobial photodynamic therapy: an overview. J Indian Soc Periodontol 2011;15:323-7.
85. Reuveni T, Motiei M, Romman Z, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed 2011;6:2859-64.
86. Rice DR, Plaunt AJ, Turkyilmaz S, et al. Evaluation of [(111)In]-labeled zinc-dipicolylamine tracers for SPECT imaging of bacterial infection. Mol Imaging Biol 2015;17:204-13.
87. Rossouw DD, Lötter MG, du Raan H, et al. Radiosynthesis and evaluation of two novel 123I-labeled 2-methyl-4-nitroimidazole derivatives as potential infection imaging agents. Nucl Med Biol 2005;32:385-94.
88. Rubin RH, Young LS, Hansen WP, et al. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med 1988;29:651-6.
89. 99m)Tclabeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med 2004;45:1201-8.
90. 99m)Tclabeled bacteriophages for infection-specific imaging. Nucl Med Biol 2008;35:433-40.
91. 18F]fluoroalkylated ciprofloxacin as a potential bacterial infection imaging agent for PET study. Bioconjugate Chem 2010;21:2282-8.
92. 99m)Tcciprofloxacin scintigraphy in a rabbitmodel of Staphylococcus aureus prosthetic joint infection. J Nucl Med 2002;43:239-45.
93. 99mTcciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2003;44:920-6.
94. 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. Eur J Nucl Med Mol I 2007;34:1302-9.
95. 99mTc-ciprofloxacin. J Nucl Med 2004;45:2088-94.
96. 99mTc-ciprofloxacin in Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Ch 2008;52:2691-2.
97. 99m) Tc and its bio-evaluation as an infection imaging agent. J Labelled Compd Rad 2014;57:652-7.
98. 99m-Infecton: a new class of radiopharmaceutical for imaging infection. J Nucl Med 1993;34:119P.
99. Strobel K, Stumpe KD. PET/CT in musculoskeletal infection. Semin Musculoskel R 2007;11:353-64.
100. Suci P, Kang S, Gmür R, et al. Targeted delivery of a photosensitizer to Aggregatibacter actinomycetemcomitans biofilm. Antimicrob Agents Ch 2010;54:2489-96.
101. Tan M, Wu X, Jeong EK, et al. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Pharm 2010;7:936-43.
102. Tang EN, Nair A, Baker DW, et al. In vivo imaging of infection using a bacteria-targeting optical nanoprobe. J Biomed Nanotechnol 2014;10:856-63.
103. Thakur ML, Zhang K, Paudyal B, et al. Targeting apoptosis for optical imaging of infection. Mol Imaging Biol 2012;14: 163-71.
104. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol 2006;62:1220-7.
105. Turchi L, Santini T, Beccari E, et al. Localization of new peptidoglycan at poles in Bacillus mycoides, a member of the Bacillus cereus group. Arch Microbiol 2012;194:887-92.
106. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-a targeting: first in-human results. Nat Med 2011;17:1315-9.
107. van Oosten M, Crane LM, Bart J, et al. Selecting potential targetable biomarkers for imaging purposes in colorectal cancer using TArget Selection Criteria (TASC): a novel target identification tool. Transl Oncol 2011;4:71-82.
108. van Oosten M, Schäfer T, Gazendam JAC, et al. Real-time in vivo imaging of invasive-and biomaterial-associated bacterial infections using fluorescently labeled vancomycin. Nat Commun 2013;4:2584
109. 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996;347:233-5.
110. Weinstein EA, Liu L, Ordonez AA, et al. Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice. Antimicrob Agents Ch 2012;56:6284-90.
111. 18Ffluorodeoxysorbitol positron emission tomography. Sci Transl Med 2014;6:259ra146.
112. 99m labelled human immunoglobulin after protein charge selection. Eur J Nucl Med 1994;21:1135-40.
113. WellingM, Feitsma HI, Calame W, et al. Localization of a bacterial infection with 99Tcm-labelled human IgG: further improvement with enriched IgG subclass preparations. Nucl Med Commun 1997;18:1057-64.
114. 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol 2002;29:413-22.
115. 99mTc-labeled human neutrophil peptide-1. J Nucl Med 1999;40:2073-80.
116. 99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000;27:292-301.
117. White AG, Fu N, Leevy WM, et al. Optical imaging of bacterial infection in living mice using deep-red fluorescent squaraine rotaxane probes. Bioconjugate Chem 2010;21:1297-304.
118. White AG, Gray BD, Pak KY, et al. Deep-red fluorescent imaging probe for bacteria. Bioorg Med Chem Lett 2012;22:2833-6.
119. Witjes JA, Redorta JP, Jacqmin D, et al. Hexaminolevulinateguided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010;57:607-14.
120. 99m labeled intact polyvalent human IgG. Nucl Med Biol 1995;22:513-9.
121. Wu PI, Edelman ER. Structural biomechanics modulate intramuscular distribution of locally delivered drugs. J Biomech 2008;41:2884-91.
122. Yao Z, Carballido-López R. Fluorescence imaging for bacterial cell biology: from localization to dynamics, from ensembles to single molecules. Annu Rev Microbiol 2014;68: 459-76.
123. 99m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjugate Chem 2011;22:369-75.